Array
(
[id] => 2194
[catid] => 313
[title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2194.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.116
[inputtime] => 2024-12-19 09:42:42
[updatetime] => 2024-12-19 09:42:42
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with severe secondary MR who remain symptomatic despite guideline-directed medical therapy (including CRT if indicated), valve intervention (transcatheter or surgical) should be considered before NCS, in eligible patients with an acceptable procedural risk.(Evidence: Level C，Recommendation: Class IIa)
[laiyuan] => 对于接受指南指导下的药物治疗（如有需要，包括心脏再同步化治疗）后症状仍然明显的重度继发性二尖瓣反流患者，在符合手术条件且可接受手术风险的情况下，应考虑在进行神经调控治疗（如深部脑刺激）之前进行瓣膜介入治疗（经导管或外科手术）。（证据级别：C；推荐强度：IIa）
[znzldj] => A
[_inputtime] => 1734572562
[_updatetime] => 1734572562
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于接受指南指导下的药物治疗（如有需要，包括心脏再同步化治疗）后症状仍然明显的重度继发性二尖瓣反流患者，在符合手术条件且可接受手术风险的情况下，应考虑在进行神经调控治疗（如深部脑刺激）之前进行瓣膜介入治疗（经导管或外科手术）。（证据级别：C；推荐强度：IIa）
In patients with severe secondary MR who remain symptomatic despite guideline-directed medical therapy (including CRT if indicated), valve intervention (transcatheter or surgical) should be considered before NCS, in eligible patients with an acceptable procedural risk.(Evidence: Level C，Recommendation: Class IIa)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 2195
[catid] => 313
[title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2195.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.116
[inputtime] => 2024-12-19 09:42:42
[updatetime] => 2024-12-19 09:42:42
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with SVT controlled by medication, it is recommended that AADs are continued during the peri-operative period.(Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 对药物控制的室上型心动过速（ SVT）患者，建议围术期不中断抗心律失常药治疗。（证据级别：C；推荐强度：I）
[znzldj] => A
[_inputtime] => 1734572562
[_updatetime] => 1734572562
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对药物控制的室上型心动过速（ SVT）患者，建议围术期不中断抗心律失常药治疗。（证据级别：C；推荐强度：I）
In patients with SVT controlled by medication, it is recommended that AADs are continued during the peri-operative period.(Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 2104
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2104.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.116
[inputtime] => 2024-12-19 09:42:41
[updatetime] => 2024-12-19 09:42:41
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => If a patient scheduled for elective NCS has chest pain or other symptoms suggestive of undetected CAD, further diagnostic work-up before NCS is recommended.(Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 术前有胸痛或其他症状提示有未确诊CAD的择期NCS患者，推荐术前进一步完善检查。（证据级别：C；推荐强度：I）
[znzldj] => A
[_inputtime] => 1734572561
[_updatetime] => 1734572561
[_nrjc] =>
[_nrsh] =>
)
推荐意见
术前有胸痛或其他症状提示有未确诊CAD的择期NCS患者，推荐术前进一步完善检查。（证据级别：C；推荐强度：I）
If a patient scheduled for elective NCS has chest pain or other symptoms suggestive of undetected CAD, further diagnostic work-up before NCS is recommended.(Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 2105
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2105.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.116
[inputtime] => 2024-12-19 09:42:41
[updatetime] => 2024-12-19 09:42:41
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => If a patient in need of acute NCS also has chest pain or other symptoms suggestive of undetected CAD, a multidisciplinary assessment approach is recommended to choose the treatment with lowest total risk for the patient.(Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 术前有胸痛或其他症状提示有未确诊CAD的急诊NCS患者，推荐进行多学科评估以选择总体风险最低的治疗方式。（证据级别：C；推荐强度：I）
[znzldj] => A
[_inputtime] => 1734572561
[_updatetime] => 1734572561
[_nrjc] =>
[_nrsh] =>
)
推荐意见
术前有胸痛或其他症状提示有未确诊CAD的急诊NCS患者，推荐进行多学科评估以选择总体风险最低的治疗方式。（证据级别：C；推荐强度：I）
If a patient in need of acute NCS also has chest pain or other symptoms suggestive of undetected CAD, a multidisciplinary assessment approach is recommended to choose the treatment with lowest total risk for the patient.(Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 2106
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] => 1
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2106.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.116
[inputtime] => 2024-12-19 09:42:41
[updatetime] => 2024-12-19 09:42:41
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with dyspnoea and/or peripheral oedema, an ECG and an NT-proBNP/BNP test is indicated before NCS, unless there is a certain non-cardiac explanation.(Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 呼吸困难和（或）外周水肿患者在 NCS 术前应检查 ECG 和 NT-proBNP / BNP ，除非已有明确的非心脏病因可解释。（证据级别：C；推荐强度：I）
[znzldj] => A
[_inputtime] => 1734572561
[_updatetime] => 1734572561
[_nrjc] =>
[_nrsh] =>
)
推荐意见
呼吸困难和（或）外周水肿患者在 NCS 术前应检查 ECG 和 NT-proBNP / BNP ，除非已有明确的非心脏病因可解释。（证据级别：C；推荐强度：I）
In patients with dyspnoea and/or peripheral oedema, an ECG and an NT-proBNP/BNP test is indicated before NCS, unless there is a certain non-cardiac explanation.(Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 2107
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2107.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.116
[inputtime] => 2024-12-19 09:42:41
[updatetime] => 2024-12-19 09:42:41
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with dyspnoea and/or peripheral oedema and elevated NT-proBNP/BNP, TTE is recommended before NCS.(Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 呼吸困难和（或）外周水肿且 NT-proBNP / BNP 升高患者应在NCS 术前完成UCG 检查。（证据级别：C；推荐强度：I）
[znzldj] => A
[_inputtime] => 1734572561
[_updatetime] => 1734572561
[_nrjc] =>
[_nrsh] =>
)
推荐意见
呼吸困难和（或）外周水肿且 NT-proBNP / BNP 升高患者应在NCS 术前完成UCG 检查。（证据级别：C；推荐强度：I）
In patients with dyspnoea and/or peripheral oedema and elevated NT-proBNP/BNP, TTE is recommended before NCS.(Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 2108
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2108.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.116
[inputtime] => 2024-12-19 09:42:41
[updatetime] => 2024-12-19 09:42:41
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => It is recommended to give patients individualized instructions for pre-operative and post-operative changes in medication, in verbal and written formats with clear and concise directions.(Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 应以口头和书面形式给患者提供术前和术后药物治疗变化的清晰而简洁的指导。（证据级别：C；推荐强度：I）
[znzldj] => A
[_inputtime] => 1734572561
[_updatetime] => 1734572561
[_nrjc] =>
[_nrsh] =>
)
推荐意见
应以口头和书面形式给患者提供术前和术后药物治疗变化的清晰而简洁的指导。（证据级别：C；推荐强度：I）
It is recommended to give patients individualized instructions for pre-operative and post-operative changes in medication, in verbal and written formats with clear and concise directions.(Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 2109
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2109.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.116
[inputtime] => 2024-12-19 09:42:41
[updatetime] => 2024-12-19 09:42:41
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => It should be considered to set up a structured information list (e.g. a check list to help with common issues) for patients with CVD or at high risk of CV complications scheduled for NCS.(Evidence: Level C，Recommendation: Class IIa)
[laiyuan] => 应给择期 NCS 的CVD 或者心血管并发症高风险的患者提供条理化的信息列表。（证据级别：C；推荐强度：IIa）
[znzldj] => A
[_inputtime] => 1734572561
[_updatetime] => 1734572561
[_nrjc] =>
[_nrsh] =>
)
推荐意见
应给择期 NCS 的CVD 或者心血管并发症高风险的患者提供条理化的信息列表。（证据级别：C；推荐强度：IIa）
It should be considered to set up a structured information list (e.g. a check list to help with common issues) for patients with CVD or at high risk of CV complications scheduled for NCS.(Evidence: Level C，Recommendation: Class IIa)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 2110
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2110.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.116
[inputtime] => 2024-12-19 09:42:41
[updatetime] => 2024-12-19 09:42:41
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients aged ≥70 years and scheduled to undergo intermediate- or high-risk NCS, frailty screening should be considered using a validated screening tool.(Evidence: Level B，Recommendation: Class IIa)
[laiyuan] => 年龄≥70岁患者行择期中高风险 NCS 时应考虑使用验证的筛查工具进行衰弱性筛查。（证据级别：B；推荐强度：IIa）
[znzldj] => A
[_inputtime] => 1734572561
[_updatetime] => 1734572561
[_nrjc] =>
[_nrsh] =>
)
推荐意见
年龄≥70岁患者行择期中高风险 NCS 时应考虑使用验证的筛查工具进行衰弱性筛查。（证据级别：B；推荐强度：IIa）
In patients aged ≥70 years and scheduled to undergo intermediate- or high-risk NCS, frailty screening should be considered using a validated screening tool.(Evidence: Level B，Recommendation: Class IIa)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 2111
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular
assessment and management of patients
undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/2111.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.116
[inputtime] => 2024-12-19 09:42:41
[updatetime] => 2024-12-19 09:42:41
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Adjusting risk assessments according to self-reported ability to climb two flights of stairs should be considered in patients referred for intermediate- or high-risk NCS.(Evidence: Level B，Recommendation: Class IIa)
[laiyuan] => 行中高风险NCS手术的患者应根据患者自己报告的爬两层楼梯的能力调整风险评估。（证据级别：B；推荐强度：IIa）
[znzldj] => A
[_inputtime] => 1734572561
[_updatetime] => 1734572561
[_nrjc] =>
[_nrsh] =>
)
推荐意见
行中高风险NCS手术的患者应根据患者自己报告的爬两层楼梯的能力调整风险评估。（证据级别：B；推荐强度：IIa）
Adjusting risk assessments according to self-reported ability to climb two flights of stairs should be considered in patients referred for intermediate- or high-risk NCS.(Evidence: Level B，Recommendation: Class IIa)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：the European Society of Anaesthesiology and Intens
